Pascal Longlade
Corporate Officer/Principal at Roche Diagnostics GmbH
Profile
Pascal Longlade is Project Manager-Cardiovascular at Roche Diagnostics GmbH.
In his past career Dr. Longlade held the position of Director-Medical Affairs at Debregeas & Associes Pharma SAS, Chief Medical Officer of Kuros Biosciences Ltd., Chief Medical Officer for Trophos SA and Director-Clinical Affairs at Abbott Vascular Devices.
Dr. Longlade received a doctorate from Faculté de Médecine Paris.
Pascal Longlade active positions
Companies | Position | Start |
---|---|---|
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Corporate Officer/Principal | - |
Former positions of Pascal Longlade
Companies | Position | End |
---|---|---|
Debregeas & Associes Pharma SAS
Debregeas & Associes Pharma SAS Medical SpecialtiesHealth Technology Debregeas & Associes Pharma SAS is an independent, privately owned French specialty pharmaceutical company founded in 2006 by Patrice Debrégeas. The company is based in Paris, France. The company promotes agility, flexibility, and efficiency in their projects and encourages their teams to think outside the box. Taking risks is part of their DNA. | Chief Tech/Sci/R&D Officer | - |
Abbott Vascular Devices
Abbott Vascular Devices Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The private company is based in Redwood City, CA. | Corporate Officer/Principal | - |
KUROS BIOSCIENCES AG | Chief Tech/Sci/R&D Officer | - |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Chief Tech/Sci/R&D Officer | - |
Training of Pascal Longlade
Faculté de Médecine Paris | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
KUROS BIOSCIENCES AG | Health Technology |
Private companies | 4 |
---|---|
Debregeas & Associes Pharma SAS
Debregeas & Associes Pharma SAS Medical SpecialtiesHealth Technology Debregeas & Associes Pharma SAS is an independent, privately owned French specialty pharmaceutical company founded in 2006 by Patrice Debrégeas. The company is based in Paris, France. The company promotes agility, flexibility, and efficiency in their projects and encourages their teams to think outside the box. Taking risks is part of their DNA. | Health Technology |
Abbott Vascular Devices
Abbott Vascular Devices Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The private company is based in Redwood City, CA. | Health Technology |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |